{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:54:00Z","timestamp":1765234440940,"version":"3.41.0"},"reference-count":79,"publisher":"Impact Journals, LLC","issue":"32","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,4,27]]},"DOI":"10.18632\/oncotarget.24962","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T21:44:08Z","timestamp":1524865448000},"page":"22254-22268","source":"Crossref","is-referenced-by-count":10,"title":["Immunohistochemically detectable metallothionein expression in malignant pleural mesotheliomas is strongly associated with early failure to platin-based chemotherapy"],"prefix":"10.18632","volume":"9","author":[{"given":"Fabian D.","family":"Mairinger","sequence":"first","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Schmeller","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Borchert","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wessolly","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mairinger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Kollmeier","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Helios Klinikum Emil von Behring, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hager","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Mairinger","sequence":"additional","affiliation":[{"name":"Department of Pathology, Helios Klinikum Emil von Behring, Berlin, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel C.","family":"Christoph","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"},{"name":"Department of Internistic Oncology, Kliniken Essen Mitte, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.H.","family":"Walter","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"},{"name":"Ruhrlandklinik, West German Lung Centre, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilfried E.E.","family":"Eberhardt","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"},{"name":"Ruhrlandklinik, West German Lung Centre, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"Pl\u00f6nes","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery and Thoracical Endoscopy, Ruhrlandklinik, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremias","family":"Wohlschlaeger","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"},{"name":"Department of Pathology, Diakonissenkrankenhaus Flensburg, Flensburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bharat","family":"Jasani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Targos Molecular Pathology GmbH, Kassel, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt Werner","family":"Schmid","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnes","family":"Bankfalvi","sequence":"additional","affiliation":[{"name":"Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/thorax.58.3.198","article-title":"Regulation of matrix metalloprotease activity in malignant mesothelioma cell lines by growth factors","volume":"58","author":"Klominek","year":"2003","journal-title":"Thorax"},{"key":"3","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/JTO.0b013e3181834f66","article-title":"Recent advances in the treatment of malignant pleural mesothelioma","volume":"3","author":"Belani","year":"2008","journal-title":"J Thorac Oncol"},{"key":"4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3816\/CLC.2009.n.014","article-title":"Malignant pleural mesothelioma: medical treatment update","volume":"10","author":"Mafafo","year":"2009","journal-title":"Clin Lung Cancer"},{"key":"5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bjc.6604442","article-title":"Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials","volume":"99","author":"Cappuzzo","year":"2008","journal-title":"Br J Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2005.04.3190","article-title":"Phase II study of pemetrexed plus carboplatin in malignant pleural mesothelioma","volume":"24","author":"Santoro","year":"2006","journal-title":"J Clin Oncol"},{"key":"7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11864-008-0071-3","article-title":"Systemic treatments for mesothelioma: standard and novel","volume":"9","author":"Kindler","year":"2008","journal-title":"Curr Treat Options Oncol"},{"key":"8","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.lungcan.2004.04.020","article-title":"Chemotherapy for malignant pleural mesothelioma: past results and recent developments","volume":"45","author":"Manegold","year":"2004","journal-title":"Lung Cancer"},{"key":"9","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/JTO.0b013e318287c224","article-title":"Reduced folate carrier and folylpolyglutamate synthetase, but not thymidylate synthase predict survival in pemetrexed-treated patients suffering from malignant pleural mesothelioma","volume":"8","author":"Popper","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/JTO.0b013e31829b1cf9","article-title":"The issue of studies evaluating biomarkers which predict outcome after pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"8","author":"Popper","year":"2013","journal-title":"J Thorac Oncol"},{"key":"11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6600673","article-title":"Chemotherapy for malignant pleural mesothelioma: past results and recent developments","volume":"88","author":"Manegold","year":"2003","journal-title":"Br J Cancer"},{"key":"12","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1021\/cr068207j","article-title":"Direct cellular responses to platinum-induced DNA damage","volume":"107","author":"Lippard","year":"2007","journal-title":"Chem Rev"},{"key":"13","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.bcp.2013.01.028","article-title":"Overcoming chemotherapy resistance of ovarian cancer cells by liposomal cisplatin: molecular mechanisms unveiled by gene expression profiling","volume":"85","author":"Bendas","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"14","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/1078-0432.CCR-09-2204","article-title":"MutS homologue 2 and the long-term benefit of adjuvant chemotherapy in lung cancer","volume":"16","author":"Fouret","year":"2010","journal-title":"Clin Cancer Res"},{"key":"15","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.lungcan.2011.04.014","article-title":"Chemotherapy and targeted therapies for unresectable malignant mesothelioma","volume":"73","author":"Hassan","year":"2011","journal-title":"Lung Cancer"},{"key":"16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.7150\/jca.16390","article-title":"Screening of pleural mesotheliomas for DNA-damage repair players by digital gene expression analysis can enhance clinical management of patients receiving platin-based chemotherapy","volume":"7","author":"Zarogoulidis","year":"2016","journal-title":"J Cancer"},{"key":"17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cllc.2013.04.013","article-title":"ERCC1, MLH1, MSH2, MSH6, and betaIII-tubulin: resistance proteins associated with response and outcome to platinum-based chemotherapy in malignant pleural mesothelioma","volume":"14","author":"Christoph","year":"2013","journal-title":"Clin Lung Cancer"},{"key":"18","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00428-017-2133-z","article-title":"miRNA regulation is important for DNA damage repair and recognition in malignant pleural mesothelioma","volume":"470","author":"Walter","year":"2017","journal-title":"Virchows Arch"},{"key":"19","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.humpath.2009.01.026","article-title":"Metallothionein overexpression and its prognostic relevance in intrahepatic cholangiocarcinoma and extrahepatic hilar cholangiocarcinoma (Klatskin tumors)","volume":"40","author":"Schmid","year":"2009","journal-title":"Hum Pathol"},{"key":"20","first-page":"3","article-title":"Expression of metallothioneins in tumor cells","volume":"55","author":"Dziegiel","year":"2004","journal-title":"Pol J Pathol"},{"key":"21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1080\/10408440802291505","article-title":"Oral exposure to inorganic arsenic: evaluation of its carcinogenic and non-carcinogenic effects","volume":"39","author":"Schneider","year":"2009","journal-title":"Crit Rev Toxicol"},{"key":"22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0006-2952(99)00301-9","article-title":"Regulation of metallothionein gene expression by oxidative stress and metal ions","volume":"59","author":"Andrews","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"23","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1073\/pnas.92.10.4452","article-title":"Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide","volume":"92","author":"Lancaster","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1756-8722-5-41","article-title":"Molecular functions of metallothionein and its role in hematological malignancies","volume":"5","author":"Takahashi","year":"2012","journal-title":"J Hematol Oncol"},{"key":"25","first-page":"149","article-title":"Metallothionein-mediated cisplatin resistance in human ovarian carcinoma cells","volume":"19","author":"Howell","year":"1987","journal-title":"Cancer Chemother Pharmacol"},{"key":"26","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2867-4-6","article-title":"Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein","volume":"4","author":"Min","year":"2004","journal-title":"Cancer Cell Int"},{"key":"27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.proghi.2008.10.001","article-title":"The role of metallothionein in oncogenesis and cancer prognosis","volume":"44","author":"Penkowa","year":"2009","journal-title":"Prog Histochem Cytochem"},{"key":"28","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/labinvest.2008.17","article-title":"Metallothionein 1G acts as an oncosupressor in papillary thyroid carcinoma","volume":"88","author":"Greco","year":"2008","journal-title":"Lab Invest"},{"key":"29","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.humpath.2011.12.014","article-title":"Combined metallothioneins and p53 proteins expression as a prognostic marker in patients with Dukes stage B and C colorectal cancer","volume":"43","author":"Baffa Trasci","year":"2012","journal-title":"Hum Pathol"},{"key":"30","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/CMR.0b013e32833d32a6","article-title":"Metallothionein 1E is methylated in malignant melanoma and increases sensitivity to cisplatin-induced apoptosis","volume":"20","author":"Gallagher","year":"2010","journal-title":"Melanoma Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/carcin\/23.1.81","article-title":"Metallothionein 2A expression is associated with cell proliferation in breast cancer","volume":"23","author":"Bay","year":"2002","journal-title":"Carcinogenesis"},{"key":"32","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/ar.21215","article-title":"Silencing the metallothionein-2A gene induces entosis in adherent MCF-7 breast cancer cells","volume":"293","author":"Bay","year":"2010","journal-title":"Anat Rec (Hoboken)"},{"key":"33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexmp.2012.10.006","article-title":"Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients","volume":"94","author":"Dziegiel","year":"2013","journal-title":"Exp Mol Pathol"},{"key":"34","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1023\/A:1010658907462","article-title":"Metallothionein 1F mRNA expression correlates with histological grade in breast carcinoma","volume":"66","author":"Tan","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.febslet.2010.12.030","article-title":"Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells","volume":"585","author":"Jeong","year":"2011","journal-title":"FEBS Lett"},{"key":"36","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3892\/ijo.2012.1570","article-title":"Role of metallothionein 1E in the migration and invasion of human glioma cell lines","volume":"41","author":"Jang","year":"2012","journal-title":"Int J Oncol"},{"key":"37","first-page":"474","article-title":"Metallothionein localization and cisplatin resistance in human hormone-independent prostatic tumor cell lines","volume":"55","author":"Lazo","year":"1995","journal-title":"Cancer Res"},{"key":"38","first-page":"2021","article-title":"Metallothionein null cells have increased sensitivity to anticancer drugs","volume":"55","author":"Lazo","year":"1995","journal-title":"Cancer Res"},{"key":"39","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/rmed.2001.1108","article-title":"p53, p21 and metallothionein immunoreactivities in patients with malignant pleural mesothelioma: correlations with the epidemiological features and prognosis of mesotheliomas with environmental asbestos exposure","volume":"95","author":"I\u015fiksoy","year":"2001","journal-title":"Respir Med"},{"key":"40","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.lungcan.2007.06.015","article-title":"DNA methylation profile of 28 potential marker loci in malignant mesothelioma","volume":"58","author":"Laird-Offringa","year":"2007","journal-title":"Lung Cancer"},{"key":"41","first-page":"493","article-title":"The expression of metallothionein (MT) and proliferation intensity in ovarian cancers treated with cisplatin and paclitaxel","volume":"62","author":"Zabel","year":"2003","journal-title":"Folia Morphol (Warsz)"},{"key":"42","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00428-006-0362-7","article-title":"Nuclear metallothionein expression correlates with cisplatin resistance of ovarian cancer cells and poor clinical outcome","volume":"450","author":"Lage","year":"2007","journal-title":"Virchows Arch"},{"key":"43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2559.2004.01922.x","article-title":"Metallothionein expression in human neoplasia","volume":"45","author":"Kouraklis","year":"2004","journal-title":"Histopathology"},{"key":"44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1745-7270.2008.00418.x","article-title":"How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes","volume":"40","author":"Xie","year":"2008","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"45","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1074\/mcp.M200008-MCP200","article-title":"Discordant protein and mRNA expression in lung adenocarcinomas","volume":"1","author":"Beer","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/1471-2164-9-246","article-title":"Correlation of mRNA and protein levels: cell type-specific gene expression of cluster designation antigens in the prostate","volume":"9","author":"Liu","year":"2008","journal-title":"BMC Genomics"},{"key":"47","first-page":"559","article-title":"The prognostic role of p53, metallothionein, P-glycoprotein, and MIB-1 in muscle-invasive urothelial transitional cell carcinoma","volume":"4","author":"Moore","year":"1998","journal-title":"Clin Cancer Res"},{"key":"48","first-page":"3","article-title":"The role of P-glycoprotein in human gastric cancer xenografts in response to chemotherapy","volume":"1","author":"Nagasue","year":"1999","journal-title":"Int J Surg Investig"},{"key":"49","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/sj.bjc.6690753","article-title":"Metallothionein expression correlates with metastatic and proliferative potential in squamous cell carcinoma of the oesophagus","volume":"81","author":"Nagasue","year":"1999","journal-title":"Br J Cancer"},{"key":"50","first-page":"3059","article-title":"Drug resistance and sensitivity of germ cell testicular tumors: evaluation of clinical relevance of MDR1\/Pgp, p53, and metallothionein (MT) proteins","volume":"18","author":"Bak","year":"1998","journal-title":"Anticancer Res"},{"key":"51","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<777::AID-IJC6>3.0.CO;2-D","article-title":"Role of metallothionein in cisplatin sensitivity of germ-cell tumours","volume":"85","author":"Mulder","year":"2000","journal-title":"Int J Cancer"},{"key":"52","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1007\/s00535-004-1471-1","article-title":"Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents","volume":"39","author":"Saisho","year":"2004","journal-title":"J Gastroenterol"},{"key":"53","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1146\/annurev.pharmtox.39.1.267","article-title":"Metallothionein: an intracellular protein to protect against cadmium toxicity","volume":"39","author":"Choudhuri","year":"1999","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.mrfmmm.2003.07.013","article-title":"Metallothioneins in human tumors and potential roles in carcinogenesis","volume":"533","author":"Bay","year":"2003","journal-title":"Mutat Res"},{"key":"55","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1124\/dmd.31.7.916","article-title":"Kinetic study on the reaction of cisplatin with metallothionein","volume":"31","author":"Souid","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jtemb.2005.03.003","article-title":"Advances in metallothionein structure and functions","volume":"19","author":"Vasak","year":"2005","journal-title":"J Trace Elem Med Biol"},{"key":"57","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00775-009-0557-x","article-title":"Reaction of human metallothionein-3 with cisplatin and transplatin","volume":"14","author":"Vasak","year":"2009","journal-title":"J Biol Inorg Chem"},{"key":"58","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1021\/jm070271l","article-title":"Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands","volume":"50","author":"Va\u0161\u00e1k","year":"2007","journal-title":"J Med Chem"},{"key":"59","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2174\/092986709787458452","article-title":"Metallothioneins and platinum(II) anti-tumor compounds","volume":"16","author":"Knipp","year":"2009","journal-title":"Curr Med Chem"},{"key":"60","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/bi026635n","article-title":"Structure, function, and aggregation of the zinc-free form of the p53 DNA binding domain","volume":"42","author":"Loh","year":"2003","journal-title":"Biochemistry"},{"key":"61","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cbpc.2007.07.010","article-title":"Zinc, antioxidant systems and metallothionein in metal mediated-apoptosis: biochemical and cytochemical aspects","volume":"146","author":"Santon","year":"2007","journal-title":"Comp Biochem Physiol C Toxicol Pharmacol"},{"key":"62","doi-asserted-by":"publisher","first-page":"18713","DOI":"10.18632\/oncotarget.7666","article-title":"microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma","volume":"7","author":"Mairinger","year":"2016","journal-title":"Oncotarget"},{"key":"63","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/bjc.2015.27","article-title":"MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14\/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53","volume":"112","author":"Wohlschlaeger","year":"2015","journal-title":"Br J Cancer"},{"key":"64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2217\/fon.13.261","article-title":"Mdm2 protein expression is strongly associated with survival in malignant pleural mesothelioma","volume":"10","author":"Wohlschlaeger","year":"2014","journal-title":"Future Oncol"},{"key":"65","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.2147\/DDDT.S87662","article-title":"Zinc supplementation induces apoptosis and enhances antitumor efficacy of docetaxel in non-small-cell lung cancer","volume":"9","author":"Kocdor","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1525-1594.2007.00412.x","article-title":"Induction of metallothionein in mesothelial cells by zinc","volume":"31","author":"Fritz","year":"2007","journal-title":"Artif Organs"},{"key":"67","first-page":"344","volume-title":"Pathology and genetics of tumours of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"68","first-page":"309","volume-title":"TNM classification of malignant tumours","volume":"xx","author":"Wittekind","year":"2010","edition":"7"},{"key":"69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","article-title":"Modified RECIST criteria for assessment of response in malignant pleural mesothelioma","volume":"15","author":"Nowak","year":"2004","journal-title":"Ann Oncol"},{"key":"70","doi-asserted-by":"publisher","first-page":"37502","DOI":"10.18632\/oncotarget.16398","article-title":"Folic acid phenotype (FAP) is a superior biomarker predicting response to pemetrexed-based chemotherapy in malignant pleural mesothelioma","volume":"8","author":"Walter","year":"2017","journal-title":"Oncotarget"},{"key":"71","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/onc.2011.270","article-title":"MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63","volume":"31","author":"Lunec","year":"2012","journal-title":"Oncogene"},{"key":"72","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/ncomms3660","article-title":"Visualization and targeted disruption of protein interactions in living cells","volume":"4","author":"Cardoso","year":"2013","journal-title":"Nat Commun"},{"key":"73","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma","volume":"15","author":"Willems","year":"2009","journal-title":"Clin Cancer Res"},{"key":"74","doi-asserted-by":"publisher","first-page":"20825","DOI":"10.18632\/oncotarget.7883","article-title":"Reciprocal positive selection for weakness - preventing olaparib resistance by inhibiting BRCA2","volume":"7","author":"Koropatnick","year":"2016","journal-title":"Oncotarget"},{"key":"75","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.lungcan.2009.04.008","article-title":"COX-2 specific inhibitors enhance the cytotoxic effects of pemetrexed in mesothelioma cell lines","volume":"67","author":"Cawkwell","year":"2010","journal-title":"Lung Cancer"},{"key":"76","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1158\/1078-0432.CCR-10-2873","article-title":"Thymidylate synthase and excision repair cross-complementing group-1 as predictors of responsiveness in mesothelioma patients treated with pemetrexed\/carboplatin","volume":"17","author":"Tunesi","year":"2011","journal-title":"Clin Cancer Res"},{"key":"77","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/bjc.1995.443","article-title":"Metallothionein expression in human breast cancer","volume":"72","author":"Nicholson","year":"1995","journal-title":"Br J Cancer"},{"key":"78","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF01607167","article-title":"Presence and possible significance of immunocytochemically demonstrable metallothionein over-expression in primary invasive ductal carcinoma of the breast","volume":"422","author":"Ofner","year":"1993","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"79","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/bioinformatics\/bts188","article-title":"NanoStringNorm: an extensible R package for the pre-processing of NanoString mRNA and miRNA data","volume":"28","author":"Boutros","year":"2012","journal-title":"Bioinformatics"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24962","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:15:12Z","timestamp":1751588112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":79,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2018,4,27]]}},"alternative-id":["24962","29854276"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24962","relation":{},"ISSN":["1949-2553"],"issn-type":[{"type":"electronic","value":"1949-2553"}],"subject":[],"published":{"date-parts":[[2018,4,27]]}}}